Dare Bioscience, Inc. (DARE)
Last updated: 2026-10-24 22:52:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Dare Bioscience, Inc. (DARE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalization of $12.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.63 to $3.78. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$12.82M | |
$0.64 | |
$79.47 | |
$0.63 | |
$0.65 | |
56.17K | |
508.30K | |
-- | |
$3.78 | |
$0.63 | |
-- | |
-- |
Dare Bioscience, Inc. (DARE) Latest Closing Stock Price
Dare Bioscience, Inc. (DARE) last closed at $0.65 as of 2026-10-23 21:29:00, unchanged from the previous close of $0.65.
During the latest regular trading session, DARE traded between $0.63 and $79.47, with a volume of 56.17K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Dare Bioscience, Inc. (DARE) 7-Day Stock Price Change
Over the past seven days, Dare Bioscience, Inc. (DARE) moved from $0.74 to $0.65, representing a decline of 11.89% ($0.09).
The stock traded between $0.63 and $0.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 150.44 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
DARE 52-Week Price Position
Position in Range: 0.9%
DARE is currently trading at $0.65, placing it 0.9% of the way from its 52-week low of $0.63 to its 52-week high of $3.78. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Dare Bioscience, Inc. (DARE)?
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Dare Bioscience, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 24 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Dare Bioscience, Inc. (DARE) Stock on MEXC
Eligible investors can buy real shares of Dare Bioscience, Inc. (DARE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Dare Bioscience, Inc. (DARE) stock price today?
2.Is DARE stock going up or down today?
3.What is DARE pre-market price?
4.What is DARE after-hours price?
5.Is DARE stock trading now?
6.Where does DARE sit relative to its 52-week high and low?
7.What sector is Dare Bioscience, Inc. in?
8.What is Dare Bioscience, Inc.'s market capitalization and where is it listed?
9.How is DARE valued in terms of P/E ratio and EPS?
10.Does Dare Bioscience, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
DARE Stock Calculator
Estimate the value between DARE shares and USD.
DARE Shares to USD
1.00 DARE shares = 0.652 USD
Calculations are estimates based on the latest available price and are for reference only.


